Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vaxart, Inc. - Common Stock (NQ:VXRT)

0.3200 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vaxart, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
On Monday, 721 companies achieved new lows for the year. 
Via Benzinga
News headline image
VAXART ALERT: Bragar Eagel & Squire, P.C. is Investigating Vaxart, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
Recap: Vaxart Q4 Earnings ↗
Vaxart (NASDAQ:VXRT) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Vaxart... 
Via Benzinga
News headline image
Vaxart Stock Crosses 2 Key Levels Friday: What's Next? ↗
Vaxart Inc. (NASDAQ:VXRT) shares were trading higher ... 
Via Benzinga
News headline image
This Reopening Stock Has A Better 1-Year Return Than Moderna, Pfizer, BioNTech, Novavax And Vaxart ↗
Macy's Inc (NYSE:M) retail stores have something for everyo... 
Via Benzinga
News headline image
Vaxart: Oral Covid-19 Vaccine Is Interesting, But Questions Linger ↗
VXRT stock is more than a Covid-19 meme trade. But is there enough fundamentals there to support an investment heading into 2022? 
Via InvestorPlace
News headline image
Wingstop, Akamai Initiations Among Today's Top Calls On Wall Street ↗
Benchmark analyst Todd Brooks initiated coverage of Wingstop (WING) with a Hold rating and no price target. The analyst believes the stock's risk/reward is balanced at these levels given the current 
Via Talk Markets
News headline image
Vaxart Deserves More Respect on Wall Street for Its Promising Covid-19 Vaccine ↗
As the Covid-19 vaccine maker expands into a second manufacturing facility, VXRT stock remains an undervalued gem. 
Via InvestorPlace
News headline image
Vaxart to Test Cross-Reactivity of its COVID-19 Oral Vaccine Against Omicron ↗
Vaxart Inc (NASDAQ: VXRT) plans to test the cross-reactivity of its oral tablet COVID-19 vaccine candidate against the omicron SARS-CoV-2 variant in two different... 
Via Benzinga
News headline image
Vaxart Stock Breaks Out Of Pennant Pattern: Now What? ↗
Vaxart Inc. (NASDAQ:VXRT) shares were trading higher ... 
Via Benzinga
News headline image
Why Vaxart Stock Is About Ready To See A Breakout ↗
Vaxart Inc. (NASDAQ:VXRT) shares are trading higher Wednes... 
Via Benzinga
News headline image
Vaxart Stock Is Being Squeezed At The End Of A Pattern ↗
Vaxart Inc. (NASDAQ:VXRT) shares are trading higher Thursd... 
Via Benzinga
News headline image
VXRT Stock: Other Vaccine Stocks Are Gaining But Jim Cramer Just Sent Vaxart Down ↗
Despite a new factory acquisition, VXRT stock is down 9% on the day as 'Mad Money' host Jim Cramer warns investors about Vaxart. 
Via InvestorPlace
News headline image
Cramer Gives His Opinion On Nokia, Delta Air Lines And More ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said DigitalOcean Holdings, Inc. (NYSE: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2021 ↗
Upgrades UBS upgraded the previous rating for ONE Gas Inc (NYSE: 
Via Benzinga
News headline image
Don’t Write Off Vaxart, As Its Oral Vaccine Still Has a Chance ↗
Vaxart stock is still worth a shot, as there's still big potential demand for a "no-needle" Covid-19 vaccine alternative. 
Via InvestorPlace
News headline image
Can This COVID Vaccine Stock Help Make You Rich? ↗
This biotech has a nifty trick potentially up its sleeve. 
Via The Motley Fool
News headline image
Why Ocugen Stock Is Rallying While Moderna, Novavax, Vaxart Can't Catch Up ↗
Ocugen Inc. (NASDAQ:OCGN) shares were trading higher Tuesd... 
Via Benzinga
News headline image
NASDAQ:VLDR Shareholder Notice: Update in Lawsuit Against Velodyne Lidar, Inc. ↗
San Diego, CA -- (SBWIRE) -- 10/12/2021 -- An update was announced in the lawsuit that was filed for certain investors in shares of Velodyne Lidar, Inc. (NASDAQ:VLDR). 
Via SBWire
Topics Lawsuit
News headline image
NASDAQ:VXRT Investor Alert: Update in Lawsuit Against Vaxart, Inc. ↗
San Diego, CA -- (SBWIRE) -- 10/12/2021 -- An update was announced in the lawsuit that was filed for certain investors in shares of Vaxart, Inc. (NASDAQ:VXRT). 
Via SBWire
Topics Lawsuit
News headline image
Vaxart May Be a COVID Vaccine Game Changer -- but Is It Too Late? ↗
The company is working on a vaccine candidate that doesn't involve a needle. 
Via The Motley Fool
News headline image
Why Vaxart Shares Are Trading Higher Today ↗
Vaxart Inc (NASDAQ: VXRT) is trading higher Friday after the company reported a Duke University-led study published in bioRxiv showed that the company's investigational... 
Via Benzinga
News headline image
18 Stocks Moving in Friday's Pre-Market Session ↗
Gainers eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) rose 25.5% to $14.41 in pre-market trading after the company, in collaboration with investigators at Baylor College of Medicine... 
Via Benzinga
News headline image
Why Vaxart Shares Are Surging In Thursday's After-Hours Session ↗
Vaxart Inc (NASDAQ: VXRT) is surging higher in after-hours trading Thursday after the company reported a Duke University-led study published in bioRxiv showed that the... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers Vaxart (NASDAQ:VXRT) shares incr... 
Via Benzinga
News headline image
Why Vaxart Stock Tumbled in September ↗
A COVID-19 antiviral pill may undermine the biotech's value proposition. 
Via The Motley Fool
News headline image
Vaxart Starts Recruitment In Mid-Stage COVID-19 Oral Vaccine Trial ↗
Vaxart Inc (NASDAQ: VXRT) has begun recruiting subjects for its Phase 2 COVID-19 oral tablet vaccine clinical trial. Related: FDA Clears Vaxart's... 
Via Benzinga
News headline image
Why Investing in VXRT Stock is a Coin Flip ↗
Vaxart is a gamble for biotechnology investors, with its upside too dependent on the approval of an oral vaccine. 
Via InvestorPlace
News headline image
What's Going On With Vaxart's Stock? ↗
Vaxart Inc. (NASDAQ: VXRT) shares traded higher Tuesday after a study titled "A Phase 2 Trial With an Oral Tableted Covid-19 Vaccine" was posted to Clinicaltrials.gov.... 
Via Benzinga
News headline image
Vaccine Stocks: Why MRNA, VXRT, CVAC and NVAX Stocks Need a Band-Aid Today ↗
Today, vaccine stocks are taking a massive hit as investors price in the potential effect of oral medications for Covid-19 on this sector. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.